Imbalance of glomerular VEGF-NO axis in diabetic rats: Prevention by chronic therapy with propyl gallate

Journal of Nephrology

Volumn 24, Issue 4, 2011, Pages 499-506

  Tian, Shaojiang ^a   Gan, Yanjie ^a   Li, Junfeng ^a   Wang, Liping ^a   Shen, Jianming ^a   Liu, Tao ^a   Ye, Tingting ^a   Liu, Huihui ^a   Liu, Dianjun ^a   Deng, Yanyan ^a   Wang, Wei ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Diabetic nephropathy; ENOS; Propyl gallate; VEGF

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GALLIC ACID PROPYL ESTER; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; GENE EXPRESSION; GLOMERULUS; HISTOPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PERIODIC ACID SCHIFF STAIN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; CATALASE; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; ENDOTHELIUM; GLUTATHIONE; KIDNEY GLOMERULUS; MALONDIALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PROPYL GALLATE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STREPTOZOCIN; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960288645     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.6458     Document Type: Article

References (17)

1. Huysman E, Mathieu C. Diabetes and peripheral vascular disease. Acta Chir Belg. 2009;109:587-594.
2. Mohan S, Reddick RL, Musi N. Diabetic eNOS knockout mice develop distinct macro-and microvascular complications. Lab Invest. 2008;88:515-528.
3. Nakagawa T. A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism. Clin Nephrol. 2009;71:103-109.
4. Nakagawa T, Sato W, Glushakova O, et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol. 2007;18:539-550.
5. Zhao HJ, Wang S, Cheng H, et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol. 2006;17:2664-2669.
6. Hohenstein B, Hugo CP, Hausknecht B, et al. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant. 2008;23:1346-1354.
7. Kamikawa A, Ishii T, Shimada K, et al. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab Res Rev. 2008;24:331-338.
8. Doi K, Noiri E, Fujita T, et al. Role of vascular endothelial growth factor in kidney disease. Curr Vasc Pharmacol. 2010;8:122-128.
9. Baelde HJ, Eikmans M, Lappin DW, et al. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int. 2007;71:637-645.
10. Satoh M, Fujimoto S, Haruna Y, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol. 2005;288:F1144-F1152.
11. Khamaisi M, Keynan S, Bursztyn M, et al. Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes. Nephron, Physiol. 2006;102:72-80.
12. Onozato ML, Tojo A, Goto A, et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 2002;61:186-194.
13. Keynan S, Hirshberg B, Levin Iaina N, et al. Renal nitric oxide production during the early phase of experimental diabetes mellitus. Kidney Int. 2000;58:740-747.
14. Ishii N, Patel KP, Lane PH, et al. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 2001;12:1630-1639.
15. Shin SJ, Lai FJ, Wen JD, et al. Neuronal and endothelial nitric oxide synthase expression in outer medulla of streptozotocininduced diabetic rat kidney. Diabetologia. 2000;43:649-659.
16. Du XL, Edelstein D, Dimmeler S, et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest. 2001;108:1341-1348.
17. Chen CH, Liu TZ, Chen CH, et al. The efficacy of protective effects of tannic acid, gallic acid, ellagic acid, and propyl gallate against hydrogen peroxide-induced oxidative stress and DNA damages in IMR-90 cells. Mol Nutr Food Res. 2007;51:962-968.